|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4292250A
(en)
|
1980-11-17 |
1981-09-29 |
Wisconsin Alumni Research Foundation |
Vitamin D derivatives
|
|
US4675189A
(en)
|
1980-11-18 |
1987-06-23 |
Syntex (U.S.A.) Inc. |
Microencapsulation of water soluble active polypeptides
|
|
US4410515A
(en)
|
1981-04-01 |
1983-10-18 |
Massachusetts General Hospital |
Vitamin D glycosides and a method of use
|
|
US4456553A
(en)
|
1982-05-07 |
1984-06-26 |
Teijin Limited |
Vitamin D3 derivatives, process for preparation thereof, and antigens comprising said derivatives to be used for preparation of antibodies for immunochemical assay and antibodies prepared therefrom
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5550111A
(en)
|
1984-07-11 |
1996-08-27 |
Temple University-Of The Commonwealth System Of Higher Education |
Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof
|
|
NZ217821A
(en)
|
1985-10-10 |
1989-07-27 |
Biotech Australia Pty Ltd |
Oral delivery system; complex of active agent and vitamin b12 or analogue thereof
|
|
JPH02274A
(ja)
|
1987-10-14 |
1990-01-05 |
Toyo Jozo Co Ltd |
新規な２５−ヒドロキシビタミンｄ↓３誘導体およびその製造法およびそれを用いた定量法
|
|
US5232836A
(en)
|
1988-05-04 |
1993-08-03 |
Ire-Medgenix S.A. |
Vitamin D derivatives: therapeutic applications and applications to assays of metabolites of vitamin D
|
|
FR2631025B1
(fr)
*
|
1988-05-04 |
1991-04-12 |
Ire Medgenix Sa |
Nouveaux derives de la vitamine d3 et application aux dosages des metabolites de la vitamine d3
|
|
US5214170A
(en)
|
1988-10-05 |
1993-05-25 |
Toyo Jozo Kabushiki Kaisha |
Radioisotope iodine-labeled 1α (or 24R), 25-dihydroxy vitamin D3
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5116964A
(en)
|
1989-02-23 |
1992-05-26 |
Genentech, Inc. |
Hybrid immunoglobulins
|
|
US5688488A
(en)
|
1989-04-03 |
1997-11-18 |
Purdue Research Foundation |
Composition and method for tumor imaging
|
|
US5108921A
(en)
|
1989-04-03 |
1992-04-28 |
Purdue Research Foundation |
Method for enhanced transmembrane transport of exogenous molecules
|
|
US5122614A
(en)
|
1989-04-19 |
1992-06-16 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
|
SE509359C2
(sv)
|
1989-08-01 |
1999-01-18 |
Cemu Bioteknik Ab |
Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
|
|
US5605690A
(en)
|
1989-09-05 |
1997-02-25 |
Immunex Corporation |
Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
|
|
US7217689B1
(en)
|
1989-10-13 |
2007-05-15 |
Amgen Inc. |
Glycosylation analogs of erythropoietin
|
|
US6395492B1
(en)
|
1990-01-11 |
2002-05-28 |
Isis Pharmaceuticals, Inc. |
Derivatized oligonucleotides having improved uptake and other properties
|
|
DE69120146T2
(de)
|
1990-01-12 |
1996-12-12 |
Cell Genesys Inc |
Erzeugung xenogener antikörper
|
|
WO1996033735A1
(en)
|
1995-04-27 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
ATE158021T1
(de)
|
1990-08-29 |
1997-09-15 |
Genpharm Int |
Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5612034A
(en)
|
1990-10-03 |
1997-03-18 |
Redcell, Inc. |
Super-globuling for in vivo extended lifetimes
|
|
WO1992014493A1
(en)
|
1991-02-20 |
1992-09-03 |
Christopher Capelli |
Non-protein intracellular receptor binding conjugates and a method of use thereof
|
|
ATE240740T1
(de)
|
1991-03-15 |
2003-06-15 |
Amgen Inc |
Pegylation von polypeptiden
|
|
US5919452A
(en)
|
1991-03-18 |
1999-07-06 |
New York University |
Methods of treating TNFα-mediated disease using chimeric anti-TNF antibodies
|
|
US7192584B2
(en)
|
1991-03-18 |
2007-03-20 |
Centocor, Inc. |
Methods of treating psoriasis with anti-TNF antibodies
|
|
DE69233046T2
(de)
|
1991-10-24 |
2004-03-04 |
Isis Pharmaceuticals, Inc., Carlsfeld |
Derivatisierte oligonukleotide mit verbessertem aufnahmevermögen
|
|
AU3423293A
(en)
|
1991-12-19 |
1993-07-19 |
Baylor College Of Medicine |
Pva or peg conjugates of peptides for epitope-specific immunosuppression
|
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
US5447851B1
(en)
|
1992-04-02 |
1999-07-06 |
Univ Texas System Board Of |
Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
|
|
US5470949A
(en)
|
1992-12-15 |
1995-11-28 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Method for making amino acid glycosides and glycopeptides
|
|
US5548064A
(en)
|
1993-05-24 |
1996-08-20 |
Biotech Australia Pty Limited |
Vitamin B12 conjugates with EPO, analogues thereof and pharmaceutical compositions
|
|
US6342225B1
(en)
|
1993-08-13 |
2002-01-29 |
Deutshces Wollforschungsinstitut |
Pharmaceutical active conjugates
|
|
JPH09509428A
(ja)
|
1994-02-23 |
1997-09-22 |
カイロン コーポレイション |
薬理学的に活性な薬剤の血清半減期を増加させるための方法および組成物
|
|
US6919441B2
(en)
|
1994-03-14 |
2005-07-19 |
Aventis Pharma Deutschland Gmbh |
Polyamide-oligonucleotide derivatives, their preparation and use
|
|
US5629384A
(en)
|
1994-05-17 |
1997-05-13 |
Consiglio Nazionale Delle Ricerche |
Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces
|
|
US5574018A
(en)
|
1994-07-29 |
1996-11-12 |
Amgen Inc. |
Conjugates of vitamin B12 and proteins
|
|
AU3999495A
(en)
|
1994-10-06 |
1996-05-02 |
Buchardt, Dorte |
Peptide nucleic acid conjugates
|
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
|
US5739277A
(en)
|
1995-04-14 |
1998-04-14 |
Genentech Inc. |
Altered polypeptides with increased half-life
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
EP0873126A4
(en)
|
1995-12-29 |
2000-04-19 |
A And D Assay Inc |
BRANDED VITAMIN COMPOUNDS AND THEIR USE
|
|
GB9526733D0
(en)
|
1995-12-30 |
1996-02-28 |
Delta Biotechnology Ltd |
Fusion proteins
|
|
US5691328A
(en)
|
1996-02-02 |
1997-11-25 |
Clarion Pharmaceuticals Inc. |
Phosphoethanolamine conjugates of vitamin D compounds
|
|
AU2538797A
(en)
|
1996-03-22 |
1997-10-10 |
Trustees Of Boston University |
Photodynamic therapy using nuclear hormone receptors to target photosensitizers
|
|
CA2722378C
(en)
|
1996-12-03 |
2015-02-03 |
Amgen Fremont Inc. |
Human antibodies that bind tnf.alpha.
|
|
JP2001511811A
(ja)
|
1997-02-13 |
2001-08-14 |
ボーン ケア インターナショナル インコーポレイテッド |
ビタミンｄ化合物の標的治療放出
|
|
US20030129194A1
(en)
*
|
1997-02-13 |
2003-07-10 |
Bone Care International, Inc. |
Targeted therapeutic delivery of vitamin D compounds
|
|
US6093701A
(en)
|
1997-12-12 |
2000-07-25 |
Mirus, Inc. |
Method for covalent attachment of compounds to genes
|
|
AU4093799A
(en)
|
1998-05-22 |
1999-12-13 |
Board Of Trustees Of The Leland Stanford Junior University |
Bifunctional molecules and therapies based thereon
|
|
US6537806B1
(en)
|
1998-06-02 |
2003-03-25 |
University Of Washington |
Compositions and methods for treating diabetes
|
|
AU763458B2
(en)
|
1998-06-25 |
2003-07-24 |
Biomedica Gmbh |
Functional vitamin D derivatives and a method for determining 25-hydroxy-vitamin D and 1alpha,25-dihydroxy-vitamin D
|
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
AU781460B2
(en)
|
1999-02-12 |
2005-05-26 |
Amgen, Inc. |
Glycosylated leptin compositions and related methods
|
|
US6713280B1
(en)
|
1999-04-07 |
2004-03-30 |
Thomas Jefferson University |
Enhancement of peptide cellular uptake
|
|
AUPQ014699A0
(en)
|
1999-05-04 |
1999-05-27 |
Access Pharmaceuticals Australia Pty Limited |
Amplification of folate-mediated targeting to tumor cells using nanoparticles
|
|
BR0010750A
(pt)
|
1999-05-17 |
2002-02-26 |
Conjuchem Inc |
Peptìdeos insulinotrópicos de longa duração
|
|
US6887470B1
(en)
|
1999-09-10 |
2005-05-03 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
|
CA2373680C
(en)
|
1999-05-17 |
2008-07-29 |
Conjuchem Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
|
AUPQ071299A0
(en)
|
1999-06-02 |
1999-06-24 |
Access Pharmaceuticals Australia Pty Limited |
Vitamin directed dual targeting therapy
|
|
ES2401939T3
(es)
|
1999-07-23 |
2013-04-25 |
Kenji Kangawa |
Nuevos péptidos
|
|
EP1240337B1
(en)
|
1999-12-24 |
2006-08-23 |
Genentech, Inc. |
Methods and compositions for prolonging elimination half-times of bioactive compounds
|
|
IL155812A0
(en)
|
2000-12-07 |
2003-12-23 |
Lilly Co Eli |
Glp-1 fusion proteins
|
|
BR0206919A
(pt)
|
2001-02-02 |
2004-07-06 |
Conjuchem Inc |
Derivados de fator de liberação de hormÈnio de crescimento de longa duração
|
|
DK1360202T3
(da)
|
2001-02-16 |
2008-09-22 |
Conjuchem Biotechnologies Inc |
Langvarigt glucagon-lignende peptid 2 (GLP-2) til behandling af gastrointestinale sygdomme og lidelser
|
|
AU2002335930B2
(en)
|
2001-03-09 |
2005-07-28 |
Morphosys Ag |
Serum albumin binding moieties
|
|
ATE295370T1
(de)
|
2001-05-31 |
2005-05-15 |
Conjuchem Inc |
Langwirkende fusionspeptid-inhibitoren für hiv- infektion
|
|
US20040259780A1
(en)
|
2001-07-30 |
2004-12-23 |
Glasebrook Andrew Lawrence |
Method for treating diabetes and obesity
|
|
EP1423136A4
(en)
|
2001-08-10 |
2007-07-25 |
Epix Pharm Inc |
POLYPEPTIDE CONJUGATES WITH EXTENDED CIRCULAR HALF TIME
|
|
US7176278B2
(en)
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
|
WO2003025139A2
(en)
|
2001-09-17 |
2003-03-27 |
Mayo Foundation For Medical Education And Research |
Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof
|
|
US6858227B1
(en)
|
2001-11-21 |
2005-02-22 |
Sonus Pharmaceuticals, Inc. |
Vitamin E conjugates
|
|
AU2002364586A1
(en)
|
2001-12-21 |
2003-07-30 |
Delta Biotechnology Limited |
Albumin fusion proteins
|
|
AU2003219770B2
(en)
|
2002-02-15 |
2008-10-09 |
Merckle Gmbh |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
|
US20040186063A1
(en)
|
2002-02-15 |
2004-09-23 |
Hans-Jurgen Gutke |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
|
US7591994B2
(en)
|
2002-12-13 |
2009-09-22 |
Immunomedics, Inc. |
Camptothecin-binding moiety conjugates
|
|
DE10209821A1
(de)
*
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Kopplung von Proteinen an ein modifiziertes Polysaccharid
|
|
ATE441429T1
(de)
|
2002-07-19 |
2009-09-15 |
Cytos Biotechnology Ag |
Ghrelin-träger-konjugate
|
|
CA2491946C
(en)
|
2002-07-23 |
2013-05-28 |
Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R |
Ghrelin analogs
|
|
JP2006514607A
(ja)
|
2002-07-31 |
2006-05-11 |
コンジュケム，インコーポレーテッド |
長時間持続性ナトリウム排泄増加性ペプチド誘導体
|
|
EP1539811A4
(en)
*
|
2002-09-16 |
2006-05-24 |
Elusys Therapeutics Inc |
PREPARATION OF BISPEQIFIC MOLECULES WITH POLYETHYLENE GLYCOL LINKER
|
|
WO2004041863A2
(en)
|
2002-11-08 |
2004-05-21 |
Ablynx N.V. |
Single domain antibodies directed against interferon- gamma and uses therefor
|
|
US20040191196A1
(en)
|
2002-12-16 |
2004-09-30 |
Dov Tamarkin |
Novel conjugate compounds and dermatological compositions thereof
|
|
US20040132104A1
(en)
|
2003-01-07 |
2004-07-08 |
Sackrison James L. |
Vitamin D assay
|
|
CN101239190B
(zh)
*
|
2003-01-27 |
2013-09-25 |
恩多塞特公司 |
维生素受体结合递药缀合物
|
|
WO2004069159A2
(en)
|
2003-01-27 |
2004-08-19 |
Endocyte, Inc. |
Vitamin receptor binding drug delivery conjugates
|
|
NZ542094A
(en)
|
2003-03-14 |
2008-12-24 |
Neose Technologies Inc |
Branched polymer conjugates comprising a peptide and water-soluble polymer chains
|
|
DK1648933T3
(da)
|
2003-07-25 |
2009-09-07 |
Conjuchem Biotechnologies Inc |
Langvarige insulinderivater og fremgangsm der
|
|
US20060193821A1
(en)
|
2004-03-05 |
2006-08-31 |
Diener John L |
Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics
|
|
WO2005097158A1
(en)
|
2004-03-29 |
2005-10-20 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Amphipathic glycopeptides
|
|
WO2005105071A1
(en)
|
2004-04-30 |
2005-11-10 |
Ben Gurion University Of The Negev Research And Development Authority Ltd. |
A topical composition containing a vitamin d derivative
|
|
US20080199960A1
(en)
|
2004-05-13 |
2008-08-21 |
Juliano Rudolph L |
Methods for the Delivery of Oligomeric Compounds
|
|
US7906137B2
(en)
*
|
2004-05-21 |
2011-03-15 |
Mediplex Corporation, Korea |
Delivery agents for enhancing mucosal absorption of therapeutic agents
|
|
WO2006023893A2
(en)
|
2004-08-23 |
2006-03-02 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Methods for modulating angiogenesis and apoptosis with apelin compositions
|
|
BRPI0606934A2
(pt)
|
2005-01-25 |
2017-07-11 |
Cell Therapeutics Inc |
Conjugado de proteína biologicamente ativa, composição, molécula de dna quimérica, vetor, célula, e, métodos para preparar conjugado de proteína biologicamente ativa, e para determinar se um dado conjugado de proteína exibe uma meia-vida de plasma modificada comparada com a meia-vida intrínseca do polipeptídeo biologicamente ativo não conjungado
|
|
US7833979B2
(en)
|
2005-04-22 |
2010-11-16 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
CA2609702C
(en)
|
2005-04-28 |
2013-05-28 |
Ventana Medical Systems, Inc. |
Antibody conjugates via heterobifunctional peg linkers
|
|
US8188223B2
(en)
|
2005-05-18 |
2012-05-29 |
Ablynx N.V. |
Serum albumin binding proteins
|
|
US8658174B2
(en)
|
2005-07-27 |
2014-02-25 |
Qinghua Wang |
GLP/1/exendin 4 IgG Fc fusion constructs for treatment of diabetes
|
|
CN101273062A
(zh)
|
2005-09-29 |
2008-09-24 |
霍夫曼-拉罗奇有限公司 |
抗25-羟基维生素d的抗体
|
|
JP2009513627A
(ja)
|
2005-10-27 |
2009-04-02 |
ペプトロン カンパニー リミテッド |
生理活性物質−血液蛋白質複合体及びこれを利用する生理活性物質の安定化方法
|
|
WO2007097934A2
(en)
|
2006-02-17 |
2007-08-30 |
Elusys Therapeutics, Inc. |
Methods and compositions for using erythrocytes as carriers for delivery of drugs
|
|
AU2007223855B2
(en)
|
2006-03-06 |
2013-05-16 |
Amunix Operating Inc. |
Unstructured recombinant polymers and uses thereof
|
|
WO2007106385A2
(en)
|
2006-03-10 |
2007-09-20 |
Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. |
Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment
|
|
GB0616111D0
(en)
|
2006-06-16 |
2006-09-20 |
Ardana Bioscience Ltd |
Agents, methods and uses
|
|
AU2007299705B2
(en)
|
2006-09-22 |
2012-09-06 |
Dharmacon, Inc. |
Duplex oligonucleotide complexes and methods for gene silencing by RNA interference
|
|
WO2008047241A2
(en)
|
2006-10-16 |
2008-04-24 |
Conjuchem Biotechnologies Inc. |
Modified corticotropin releasing factor peptides and uses thereof
|
|
US20100104626A1
(en)
|
2007-02-16 |
2010-04-29 |
Endocyte, Inc. |
Methods and compositions for treating and diagnosing kidney disease
|
|
CA2678646A1
(en)
|
2007-03-05 |
2008-09-12 |
Syracuse University |
A conjugate of insulin and vitamin b12 for oral delivery
|
|
AU2008224988A1
(en)
|
2007-03-14 |
2008-09-18 |
Endocyte, Inc. |
Binding ligand linked drug delivery conjugates of tubulysins
|
|
PL2308514T3
(pl)
|
2007-03-23 |
2013-11-29 |
To Bbb Holding B V |
Koniugaty do ukierunkowanego dostarczania leku poprzez barierę krew-mózg
|
|
EP2152297B1
(en)
|
2007-05-31 |
2015-04-29 |
Alizé Pharma SAS |
Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders
|
|
CN101784565B
(zh)
|
2007-06-25 |
2014-12-10 |
恩多塞特公司 |
含有亲水性间隔区接头的共轭物
|
|
WO2009045457A2
(en)
|
2007-10-02 |
2009-04-09 |
Rxi Pharmaceuticals Corp. |
Tripartite rnai constructs
|
|
US8076476B2
(en)
|
2007-11-15 |
2011-12-13 |
Avi Biopharma, Inc. |
Synthesis of morpholino oligomers using doubly protected guanine morpholino subunits
|
|
TWI489994B
(zh)
|
2008-03-17 |
2015-07-01 |
Baxter Healthcare Sa |
供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法
|
|
CN102065903B
(zh)
|
2008-04-01 |
2015-02-18 |
诺沃-诺迪斯克有限公司 |
胰岛素清蛋白缀合物
|
|
KR101350251B1
(ko)
|
2008-05-23 |
2014-01-14 |
다이이찌 산쿄 가부시키가이샤 |
목적 펩타이드의 혈장내 반감기 연장 작용을 가진 펩타이드
|
|
US8034770B2
(en)
|
2008-06-04 |
2011-10-11 |
Amgen Inc. |
FGF21 polypeptides comprising two or more mutations
|
|
TWI451876B
(zh)
|
2008-06-13 |
2014-09-11 |
Lilly Co Eli |
聚乙二醇化之離脯胰島素化合物
|
|
CN102131516B
(zh)
|
2008-06-27 |
2016-03-16 |
杜克大学 |
包含弹性蛋白样肽的治疗剂
|
|
WO2010033240A2
(en)
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Carbohydrate-based drug delivery polymers and conjugates thereof
|
|
EP2342340A1
(en)
|
2008-09-22 |
2011-07-13 |
Rxi Pharmaceuticals Corporation |
Rna interference in skin indications
|
|
US8609383B2
(en)
|
2008-12-10 |
2013-12-17 |
The Scripps Research Institute |
Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
|
|
US20120028887A1
(en)
|
2009-04-01 |
2012-02-02 |
Yeda Research And Development Co. Ltd. |
Lipopeptide inhibitors of hiv-1
|
|
JP5727459B2
(ja)
|
2009-04-22 |
2015-06-03 |
アルテオゼン， インクＡｌｔｅｏｇｅｎ， Ｉｎｃ |
体内持続性を維持することにより体内半減期が増加したタンパク質またはペプチド融合体
|
|
WO2010129600A2
(en)
|
2009-05-05 |
2010-11-11 |
Amgen Inc. |
Fgf21 mutants and uses thereof
|
|
WO2010129503A1
(en)
|
2009-05-05 |
2010-11-11 |
Amgen Inc. |
Fgf21 mutants and uses thereof
|
|
US20120165377A1
(en)
|
2009-09-28 |
2012-06-28 |
Kowa Co., Ltd. |
Agent for reducing visceral fat weight
|
|
US20110097733A1
(en)
|
2009-10-27 |
2011-04-28 |
Michel Anciaux |
Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin d metabolite
|
|
EP2515913A2
(en)
|
2009-12-23 |
2012-10-31 |
Glycomyr Inc. |
Use of vitamin d glycosides and sulfates for treatment of disease
|
|
RS59459B1
(sr)
|
2010-01-22 |
2019-11-29 |
Novo Nordisk Healthcare Ag |
Hormoni rasta sa produženom in-vivo efikasnošću
|
|
ES2993140T3
(en)
|
2010-04-02 |
2024-12-23 |
Amunix Pharmaceuticals Inc |
Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same
|
|
EP2571992B1
(en)
|
2010-05-21 |
2018-04-25 |
Merrimack Pharmaceuticals, Inc. |
Bi-specific fusion proteins
|
|
US9377466B2
(en)
|
2010-09-06 |
2016-06-28 |
Modpro Ab |
Compounds and methods
|
|
BR112013007160A2
(pt)
*
|
2010-09-29 |
2016-06-14 |
Philogen Spa |
ligante tiazolidina para a conjugação de fármacos a anticorpos
|
|
US9023791B2
(en)
|
2010-11-19 |
2015-05-05 |
Novartis Ag |
Fibroblast growth factor 21 mutations
|
|
CN108892709A
(zh)
|
2011-05-18 |
2018-11-27 |
欧莫德里斯制药公司 |
改良的肽药物
|
|
US8785603B2
(en)
|
2011-05-20 |
2014-07-22 |
Siemens Healthcare Diagnostics Inc. |
Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof
|
|
WO2013033230A1
(en)
|
2011-08-29 |
2013-03-07 |
Isis Pharmaceuticals, Inc. |
Oligomer-conjugate complexes and their use
|
|
MX2014002260A
(es)
|
2011-08-31 |
2014-08-18 |
Amgen Inc |
Factor de crecimiento de fibroblasto 21 para usar en el tratamiento de diabetes tipo 1.
|
|
JP6206972B2
(ja)
|
2011-09-12 |
2017-10-04 |
アムニクス オペレーティング インコーポレイテッド |
グルカゴン様ペプチド−２組成物およびその作製法および使用法
|
|
UY34347A
(es)
|
2011-09-26 |
2013-04-30 |
Novartis Ag |
Proteínas de función dual para tratar trastornos metabólicos
|
|
US20140256626A1
(en)
|
2011-10-18 |
2014-09-11 |
Prolynx Llc |
Peg conjugates of exenatide
|
|
BR112014014898A2
(pt)
|
2011-12-22 |
2020-10-27 |
Pfizer Inc. |
processo para purificar uma amostra de anticorpo h38c2, ou variante do mesmo, e composição compreendendo o referido h38c2
|
|
WO2013131091A1
(en)
|
2012-03-02 |
2013-09-06 |
New York University |
Chimeric fgf21 proteins with enhanced binding affinity for beta-klotho for the treatment of type ii diabetes, obesity and related metabolic disorders
|
|
US20150111246A1
(en)
|
2012-04-24 |
2015-04-23 |
Astrazeneca Pharmaceuticals Lp |
Site-specific enzymatic modification of exendins and analogs thereof
|
|
AU2013263349B2
(en)
|
2012-05-17 |
2016-09-08 |
Extend Biosciences, Inc |
Carriers for improved drug delivery
|
|
US9464126B2
(en)
|
2012-06-07 |
2016-10-11 |
New York University |
Chimeric fibroblast growth factor 21 proteins and methods of use
|
|
CA2884338A1
(en)
|
2012-09-11 |
2014-03-20 |
Unisense Diagnostics Aps |
Detection of non-nucleic acid analytes using strand displacement exchange reactions
|
|
ES2906975T3
(es)
|
2012-11-20 |
2022-04-21 |
Eumederis Pharmaceuticals Inc |
Productos farmacéuticos de péptidos mejorados
|
|
US9290557B2
(en)
|
2012-11-28 |
2016-03-22 |
Ngm Biopharmaceuticals, Inc. |
Compositions comprising variants and fusions of FGF19 polypeptides
|
|
US9244083B2
(en)
|
2012-11-30 |
2016-01-26 |
Siemens Healthcare Diagnostics Inc. |
Compositions and methods for detecting vitamin D
|
|
CA2913029A1
(en)
|
2012-12-10 |
2014-06-19 |
Fred Hutchinson Cancer Research Center |
Lipocalin fusion partners
|
|
AU2013374345A1
(en)
|
2013-01-17 |
2015-08-06 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
|
CA3100071A1
(en)
*
|
2018-05-16 |
2019-11-21 |
Csl Limited |
Soluble complement receptor type 1 variants and uses thereof
|